Lineage Cell Therapeutics's top three insider shareholders as of April 17, 2026 are Partners, L.P. Broadwood (Director, 49.56Mn shares), Brian M Culley (President And Ceo, 255.52K shares), Don M Bailey (Director, 158.80K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Partners, L.P. Broadwood | - | 49,560,992 | 0 | 28 Jan, 2025 |
| Brian M Culley | President And Ceo | 255,516 | 0 | 12 Mar, 2026 |
| Don M Bailey | - | 0 | 158,801 | 08 Feb, 2024 |
| Brian M Culley | President And Ceo | 144,842 | 0 | 12 Feb, 2024 |
| Dipti Amin | - | 35,000 | 0 | 29 Mar, 2022 |
| George A. Iii Samuel | General Counsel And Secretary | 31,063 | 0 | 13 Feb, 2026 |
| Jill Ann Howe | Chief Financial Officer | 25,500 | 0 | 26 Nov, 2024 |
| Anula Jayasuriya | - | 10,000 | 0 | 02 Jan, 2024 |
| Gary S. Hogge | Svp,Clinical Medical Affairs | 7,710 | 0 | 14 Feb, 2023 |
| George A. Iii Samuel | General Counsel/Secretary | 7,184 | 0 | 12 Feb, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Brian M Culley | Common Shares | A | 15,000 | $1.63 | 255,516 | D | P |
| 05 Mar, 2026 | Jill Ann Howe | Employee Stock Option (Right to Buy) | A | 1,050,000 | $0.00 | 1,050,000 | D | A |
| 05 Mar, 2026 | Brian M Culley | Employee Stock Option (Right to Buy) | A | 3,250,000 | $0.00 | 3,250,000 | D | A |
| 05 Mar, 2026 | George A. Iii Samuel | Employee Stock Option (Right to Buy) | A | 900,000 | $0.00 | 900,000 | D | A |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | A | 6,075 | - | 33,565 | D | M |
| 11 Feb, 2026 | Brian M Culley | Common Shares | A | 31,250 | - | 253,385 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | D | 2,502 | $1.80 | 31,063 | D | F |
| 11 Feb, 2026 | Brian M Culley | Common Shares | D | 12,869 | $1.80 | 240,516 | D | F |
| 11 Feb, 2026 | George A. Iii Samuel | Restricted Stock Units | D | 6,075 | $0.00 | 0 | D | M |
| 11 Feb, 2026 | Brian M Culley | Restricted Stock Units | D | 31,250 | $0.00 | 0 | D | M |
| 19 Dec, 2025 | Brian M Culley | Common Shares | A | 8,925 | - | 222,469 | D | A |
| 19 Dec, 2025 | George A. Iii Samuel | Common Shares | A | 1,735 | - | 27,555 | D | A |
| 19 Dec, 2025 | Brian M Culley | Common Shares | D | 334 | $1.68 | 222,135 | D | F |
| 19 Dec, 2025 | George A. Iii Samuel | Common Shares | D | 65 | $1.68 | 27,490 | D | F |
| 01 Jul, 2025 | Neal C Bradsher | OPTION TO PURCHASE COMMON SHARES | A | 75,000 | $0.00 | 75,000 | D | A |
| 01 Jul, 2025 | Dipti Amin | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 01 Jul, 2025 | Deborah J Andrews | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 01 Jul, 2025 | Anula Jayasuriya | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 10 Mar, 2025 | George A. Iii Samuel | Employee Stock Option (Right to Buy) | A | 750,000 | $0.00 | 750,000 | D | A |
| 10 Mar, 2025 | Jill Ann Howe | Employee Stock Option (Right to Buy) | A | 750,000 | $0.00 | 750,000 | D | A |